Correlation Between Ultragenyx and Novo Nordisk
Can any of the company-specific risk be diversified away by investing in both Ultragenyx and Novo Nordisk at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Ultragenyx and Novo Nordisk into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Ultragenyx and Novo Nordisk AS, you can compare the effects of market volatilities on Ultragenyx and Novo Nordisk and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Ultragenyx with a short position of Novo Nordisk. Check out your portfolio center. Please also check ongoing floating volatility patterns of Ultragenyx and Novo Nordisk.
Diversification Opportunities for Ultragenyx and Novo Nordisk
0.85 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between Ultragenyx and Novo is 0.85. Overlapping area represents the amount of risk that can be diversified away by holding Ultragenyx and Novo Nordisk AS in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Novo Nordisk AS and Ultragenyx is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Ultragenyx are associated (or correlated) with Novo Nordisk. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Novo Nordisk AS has no effect on the direction of Ultragenyx i.e., Ultragenyx and Novo Nordisk go up and down completely randomly.
Pair Corralation between Ultragenyx and Novo Nordisk
Given the investment horizon of 90 days Ultragenyx is expected to under-perform the Novo Nordisk. In addition to that, Ultragenyx is 1.25 times more volatile than Novo Nordisk AS. It trades about -0.22 of its total potential returns per unit of risk. Novo Nordisk AS is currently generating about -0.15 per unit of volatility. If you would invest 11,236 in Novo Nordisk AS on August 27, 2024 and sell it today you would lose (730.00) from holding Novo Nordisk AS or give up 6.5% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Strong |
| Accuracy | 100.0% |
| Values | Daily Returns |
Ultragenyx vs. Novo Nordisk AS
Performance |
| Timeline |
| Ultragenyx |
| Novo Nordisk AS |
Ultragenyx and Novo Nordisk Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Ultragenyx and Novo Nordisk
The main advantage of trading using opposite Ultragenyx and Novo Nordisk positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Ultragenyx position performs unexpectedly, Novo Nordisk can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Novo Nordisk will offset losses from the drop in Novo Nordisk's long position.| Ultragenyx vs. X4 Pharmaceuticals | Ultragenyx vs. Terns Pharmaceuticals | Ultragenyx vs. Day One Biopharmaceuticals | Ultragenyx vs. PDS Biotechnology Corp |
| Novo Nordisk vs. Regeneron Pharmaceuticals | Novo Nordisk vs. Crispr Therapeutics AG | Novo Nordisk vs. Sarepta Therapeutics | Novo Nordisk vs. Intellia Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Other Complementary Tools
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |